Single-session Prolonged Alcohol-retention Sclerotherapy for Large Hepatic Cysts
Overview
Authors
Affiliations
Objective: Our purpose was to evaluate the safety and therapeutic efficacy of single-session prolonged alcohol sclerotherapy in treating large hepatic cysts. A therapeutic comparison between 4-hour and 2-hour retention techniques was also studied.
Materials And Methods: Twenty-seven patients with 31 hepatic cysts were enrolled in this study. Seventeen patients (18 cysts) were treated by alcohol retention for 4 hours (group 1) and 10 patients (13 cysts) for 2 hours (group 2). The mean diameter of the hepatic cysts was 12.4 cm (range, 8-23 cm) with a comparable size range in each group. The sclerosing agent used was 95% alcohol, and the maximum amount was limited to 200 mL. Patients changed position and vital signs were monitored every 10-15 minutes. The blood alcohol concentrations were checked hourly for 5 consecutive hours in the initial nine patients. The nonparametric Mann-Whitney U test was used to compare the difference in characteristics and treatment results of the subjects between these two groups. The level of statistical significance was set at a p value of less than 0.05.
Results: All but one patient in group 2 tolerated the entire course of sclerotherapy. The mean aspirated volume and mean injected alcohol volume of the hepatic cysts were 730 mL and 138.3 mL, respectively, in group 1 patients, and 931 mL and 139 mL, respectively, in group 2 patients. The mean maximum blood alcohol concentration was 128.2 mg/dL (range, 60-199 mg/dL) at 3-4 hours after alcohol instillation. The mean posttherapy residual cystic diameter was 2.5 cm (range, 0-6 cm), with an average volume reduction rate of 98.3% and 97.7%, respectively, for patients in group 1 and group 2 after a mean follow-up period of 29.6 months (9-59 months). No statistical differences of the mean reduction rate between the two groups were noted.
Conclusion: Long retention of the alcohol in a single-injection technique is safe and effective. Two-hour alcohol retention has a comparable efficacy to that of 4-hour retention.
Kim R, Oh J, Kim S, Chun H J Clin Med. 2024; 13(5).
PMID: 38592276 PMC: 10932187. DOI: 10.3390/jcm13051472.
Successful minimally invasive simple hepatic cyst ablation via ethanol sclerotherapy in a cat.
Pfahl M, Gallaher H JFMS Open Rep. 2023; 9(2):20551169231215273.
PMID: 38115861 PMC: 10729625. DOI: 10.1177/20551169231215273.
He X, Sun M, Lv K, Cao J, Zhang S, Li J World J Gastrointest Surg. 2022; 14(7):706-713.
PMID: 36158281 PMC: 9353755. DOI: 10.4240/wjgs.v14.i7.706.
Mo Z, Yang F, Lv L, He J, Gou Q, Chen X Front Med (Lausanne). 2022; 9:737694.
PMID: 35911390 PMC: 9334720. DOI: 10.3389/fmed.2022.737694.
Ethanol sclerotherapy or polidocanol sclerotherapy for symptomatic hepatic cysts.
Wijnands T, Schoenemeier B, Potthoff A, Gevers T, Groenewoud H, Gebel M United European Gastroenterol J. 2018; 6(6):919-925.
PMID: 30023070 PMC: 6047294. DOI: 10.1177/2050640618764940.